https://www.selleckchem.com/products/ca3.html
Neuroprotection against Parkinson's disease degeneration by photobiomodulation has been reported in animal models but no true placebo-controlled human studies have been published. To understand if photobiomodulation therapy can produce clinically significant differences in physical performance measures in people with Parkinson's disease; and what frequency of treatment is necessary to initiate clinical change. In a participant and assessor-blinded, randomized, placebo-controlled pilot study, 22 participants received either sham and/or activ
Respect!
Kommentar
Delen
